Pensionfund PDN Purchases New Shares in Sabra Healthcare REIT, Inc. $SBRA

Pensionfund PDN purchased a new position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 97,730 shares of the real estate investment trust’s stock, valued at approximately $1,851,000. Sabra Healthcare REIT makes up about 1.2% of Pensionfund PDN’s portfolio, making the stock its 24th biggest holding.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Vanguard Group Inc. grew its position in shares of Sabra Healthcare REIT by 0.5% in the third quarter. Vanguard Group Inc. now owns 34,948,785 shares of the real estate investment trust’s stock valued at $651,445,000 after purchasing an additional 179,670 shares during the period. Bank of America Corp DE raised its position in shares of Sabra Healthcare REIT by 9.4% during the 3rd quarter. Bank of America Corp DE now owns 5,224,116 shares of the real estate investment trust’s stock worth $97,378,000 after purchasing an additional 447,528 shares during the last quarter. Northern Trust Corp lifted its stake in Sabra Healthcare REIT by 1.1% in the 3rd quarter. Northern Trust Corp now owns 3,930,245 shares of the real estate investment trust’s stock valued at $73,260,000 after buying an additional 43,927 shares in the last quarter. JPMorgan Chase & Co. lifted its stake in Sabra Healthcare REIT by 33.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 3,589,253 shares of the real estate investment trust’s stock valued at $66,904,000 after buying an additional 903,841 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its holdings in Sabra Healthcare REIT by 2.4% in the 3rd quarter. Dimensional Fund Advisors LP now owns 3,399,083 shares of the real estate investment trust’s stock worth $63,358,000 after buying an additional 78,586 shares during the last quarter. 99.40% of the stock is owned by hedge funds and other institutional investors.

Sabra Healthcare REIT Stock Up 0.5%

Shares of NASDAQ SBRA opened at $19.69 on Tuesday. The stock has a market cap of $4.96 billion, a PE ratio of 30.77, a P/E/G ratio of 1.56 and a beta of 0.64. The company has a current ratio of 4.29, a quick ratio of 4.29 and a debt-to-equity ratio of 0.90. Sabra Healthcare REIT, Inc. has a 12-month low of $15.75 and a 12-month high of $21.07. The company has a 50-day moving average of $19.76 and a 200 day moving average of $19.06.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its earnings results on Thursday, February 12th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing analysts’ consensus estimates of $0.37 by ($0.26). The business had revenue of $201.35 million during the quarter, compared to analysts’ expectations of $201.97 million. Sabra Healthcare REIT had a return on equity of 5.63% and a net margin of 20.09%.The company’s revenue for the quarter was up 16.2% compared to the same quarter last year. During the same period last year, the business earned $0.36 earnings per share. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. As a group, sell-side analysts predict that Sabra Healthcare REIT, Inc. will post 1.45 EPS for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, February 27th. Investors of record on Friday, February 13th were given a dividend of $0.30 per share. The ex-dividend date was Friday, February 13th. This represents a $1.20 dividend on an annualized basis and a yield of 6.1%. Sabra Healthcare REIT’s dividend payout ratio (DPR) is presently 187.50%.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on the company. Citigroup increased their target price on Sabra Healthcare REIT from $21.00 to $24.00 and gave the company a “buy” rating in a report on Wednesday, February 18th. Weiss Ratings raised Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (a-)” rating in a research note on Wednesday, March 18th. Jefferies Financial Group reiterated a “buy” rating and set a $22.00 price target on shares of Sabra Healthcare REIT in a research report on Monday, December 15th. Scotiabank increased their price objective on Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “sector perform” rating in a research note on Monday, March 2nd. Finally, Truist Financial raised their price objective on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “hold” rating in a report on Friday, March 13th. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $21.90.

Sabra Healthcare REIT Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.